Glaukos’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Glaukos is an ophthalmic medical device firm that creates micro invasive glaucoma surgery options for patients. Read more

Thomas W Burns's photo - President & CEO of Glaukos

President & CEO

Thomas W Burns

CEO Approval Rating

88/100

Founded:

2001

Status:

PublicNYSEGKOS

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Ivantis is Glaukos's biggest rival. Ivantis was founded in 2007, and is headquartered in Irvine, California. Ivantis competes in the Health Care Equipment industry. Ivantis generates $207.8M less revenue vs. Glaukos.

GluMetrics is one of Glaukos's top competitors. GluMetrics's headquarters is in Irvine, California, and was founded in null. GluMetrics operates in the industry. GluMetrics generates NaN% of Glaukos's revenue.

Western States Pharmacy Coalition is seen as one of Glaukos's top competitors. Western States Pharmacy Coalition is a Private company that was founded in null in , . Western States Pharmacy Coalition is in the field. Compared to Glaukos, Western States Pharmacy Coalition has NaN fewer employees.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is NeuroPace a competitor of Glaukos?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$211.3M

Glaukos's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 23.7M. Over the last four quarters, Glaukos's revenue has decreased by 46.1%. Specifically, in Q2 2020's revenue was $31.6M; in Q1 2020, it was $55.3M; in Q4 2019, it was $65.8M; in Q3 2019, Glaukos's revenue was $58.5M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Avedro Inc

Aug 2019

Source »
undisclosed
Avedro develops and commercializes cross-linking systems and riboflavin products for the treatment of corneal ectasia disorders.

-

-

Jun 2019

Source »
$2.5M
-

These are all the companies that Glaukos has acquired. Glaukos has acquired 2 companies and its latest acquisition was Avedro Inc in Aug 2019. Avedro develops and commercializes cross-linking systems and riboflavin products for the treatment of corneal ectasia disorders.

Glaukos Funding History

$108M

Since Glaukos was founded in 2001, it has participated in 1 round of funding. In total Glaukos has raised $108.0M. Glaukos' funding round was on Jun 2015 for a total of $108.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Jun 2015
$108M

Total Funding: $108M

Since Glaukos was founded in 2001, it has participated in 1 round of funding. In total Glaukos has raised $108.0M. Glaukos' funding round was on Jun 2015 for a total of $108.0M

Investments

No recent investments found related to Glaukos

Glaukos News

August 6, 2020BioSpace

Glaukos Corporation Announces Second Quarter 2020 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused... See more »
June 19, 2020Orange County Business Journal

Future Glaukos HQ Trades for $73.5M

160,000 SF office campus sells... See more »
June 8, 2020FIRSTWORD PHARMA

Glaukos Corporation Announces Proposed Private Offering of $200 Million of Convertible Senior Notes

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS) (the “Company” or “Glaukos”),... See more »
May 14, 2020MarketScreener

Technologies Featured in Numerous Presentations at the 2020 American Society of Cataract and Refractive Surgery Virtual Annual Meeting

(marketscreener.com) Dr. Samuelson to Present First-of-its-Kind MIGS Prospective Study Demonstrating ... See more »

Glaukos Press Releases

April 30, 2019Business Wire

Glaukos Announces Participation in Bank of America Merrill Lynch 2019 Health Care Conference

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techno... See more »
December 19, 2018StreetInsider

Glaukos Announces Participation in J.P. Morgan Healthcare Conference

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techn... See more »
December 11, 2018StreetInsider

Glaukos iStent inject® Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burden, According to New Study

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused... See more »
December 11, 2018Business Wire

Glaukos iStent inject® Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burden, According to New Study

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techno... See more »
October 26, 2018Business Wire

Glaukos Technologies Featured in Presentations at 2018 American Academy of Ophthalmology Conference

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techno... See more »
June 13, 2018Business Wire

Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of Over 30% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery, T... See more »
May 9, 2018StreetInsider

Glaukos Corporation Announces First Quarter 2018 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused... See more »

Headquarters

229 Avenida Fabricante

San Clemente, California92672

949-367-9600

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Glaukos is an ophthalmic medical device firm that creates micro invasive glaucoma surgery options for patients. Glaukos was founded in 2001. Glaukos' headquarters is located in San Clemente, California, USA 92672. It has raised 108.0M in 1 round. The ...

CEO

Glaukos's President & CEO, Thomas W Burns, currently has an approval rating of 88%. Glaukos's primary competitors are Ivantis, GluMetrics & Western States Pharmacy Coalition.

Website

glaukos.com

Frequently Asked Questions about Glaukos

  1. When was Glaukos founded?

    Glaukos was founded in 2001
  2. Who is Glaukos's CEO?

    Glaukos's CEO is Thomas W Burns
  3. How much revenue does Glaukos generate?

    Glaukos generates $211.3M in revenue
  4. How much funding does Glaukos have?

    Glaukos has historically raised $108M in funding
  1. Where is Glaukos's headquarters?

    Glaukos's headquarters is in San Clemente California, USA
  2. How many employees does Glaukos have?

    Glaukos has 437 employees
  3. What sector does Glaukos operate in?

    Glaukos is in Health Care Technology
  4. Who are Glaukos's competitors?

    Glaukos's top competitors are Ivantis, GluMetrics, Western States Pharmacy Coalition